Infants May Lose Measles Protection By Six Months Old

New research suggests maternal antibodies fade early, raising questions on the timing of the first vaccine dose for babies.

Updated on Oct. 23, 2026 in Babies

Infants May Lose Measles Protection By Six Months Old

Live Poll

Is it time to shift the first measles vaccine dose to an earlier age for infants?

A retrospective analysis reveals that most infants in the U.S. lose maternal measles antibodies by 6 months of age, suggesting they may become susceptible to infection earlier than previously estimated. This finding, published on October 23, 2026, prompts new questions regarding the optimal timing for the first measles vaccine dose.

Why it matters

Understanding when maternal protection wanes is critical as the U.S. faces rising measles cases, with 4,588 reports documented as of October 22, 2026. This data helps clinicians and parents evaluate the balance between early immunization and the efficacy of vaccines administered before the standard 12-to-15-month window.

This retrospective analysis of serum from maternal-infant pairs found that measles neutralizing antibodies generally fall below the 120 mIU/mL correlate of protection by 6 months. Researchers noted that only 8.7% to 19.6% of infants remained seropositive for specific measles strains at this age.

The players

CDC

The federal agency responsible for national health protection and the tracking of infectious disease outbreaks.

Vanderbilt University

The institution where researchers conducted the analysis using samples from the MOMI-Vax and Mix & Match studies.

The details

Maternal antibodies transferred through the placenta provide temporary immunity to newborns, but this protection declines over time as the infant's immune system matures. The analysis showed that infants born to mothers born after the 1967 measles eradication program launch generally have 4 months of protection, while those with mothers born before 1967 have about 6 months. Because 96% of recent cases have occurred in the unvaccinated, protecting infants during this immunity gap is a significant public health focus.

1967: Launch of the U.S. measles eradication program.
October 22, 2026: CDC reported 4,588 measles cases in the U.S.
October 23, 2026: Publication date of the report.

Health Landscape

This research provides a necessary update to our understanding of population-level immunity since the launch of the 1967 U.S. measles eradication program. It highlights an evolving landscape where the duration of passive maternal protection may be shorter than historical norms.

If you are concerned about your infant's exposure risk during the current measles surge, discuss the recommended vaccine schedule with your pediatrician. They can explain how the timing of the first dose is determined based on both local outbreak activity and your child's specific health needs.

The takeaway

Measles protection from maternal antibodies typically wanes by the time an infant reaches 6 months of age. Because most current measles cases involve unvaccinated individuals, it is worth tracking local outbreak updates and discussing the latest vaccine timing guidelines with your doctor.